Are There Anxiety Medications That Don’t Cause Drowsiness?

Several widely prescribed anxiety medications carry little to no drowsiness as a side effect, and some are even mildly stimulating. The most commonly used non-sedating options include selective serotonin reuptake inhibitors (SSRIs) like fluoxetine and sertraline, serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine and duloxetine, and the standalone anxiolytic buspirone. That said, “non-sedating” does not mean “side-effect-free,” and the degree of sleepiness any particular drug causes varies from person to person in ways that can be hard to predict before trying it.

SSRIs and SNRIs as First-Line Options

SSRIs and SNRIs are the medications most doctors reach for first when treating generalized anxiety, social anxiety, or panic disorder. They work by increasing the availability of serotonin (and, in the case of SNRIs, norepinephrine) in the brain. From a drowsiness standpoint, many of these drugs lean in the opposite direction. Fluoxetine and venlafaxine, for instance, are often described as “activating” antidepressants, meaning they can actually make sleep harder to come by rather than causing daytime sleepiness.

A review in Current Psychiatry Reports noted that activating antidepressants like fluoxetine and venlafaxine may disrupt sleep during short-term treatment, while sedating antidepressants such as mirtazapine and trazodone rapidly improve sleep but risk oversedation with longer use.¹ This is useful information if drowsiness is the specific side effect you want to avoid. Fluoxetine, sertraline, and escitalopram are all SSRIs commonly prescribed for anxiety that tend not to make people sleepy during the day. If anything, the early weeks of treatment can bring a jittery, slightly wired feeling that usually fades as your body adjusts.

SNRIs add norepinephrine reuptake inhibition on top of serotonin effects, which raises a reasonable concern: doesn’t boosting norepinephrine, the brain’s alertness chemical, risk making anxiety worse? A review in Neuropsychiatric Disease and Treatment looked specifically at this question and found that across all the studies examined, enhanced noradrenergic activity did not promote the emergence of anxiety as a treatment side effect.² In practical terms, SNRIs like venlafaxine and duloxetine treat anxiety effectively without sedation, and the norepinephrine component may actually help with fatigue and concentration problems that often accompany anxiety disorders.

Buspirone Stands Apart

Buspirone is in a class by itself. It is not an antidepressant, not a benzodiazepine, and not an antihistamine. It was designed specifically for generalized anxiety disorder and works by acting on serotonin receptors in a targeted way. What makes it attractive for people worried about drowsiness is that it has a notably narrow side-effect profile compared to most other anxiolytics. Research has highlighted its lack of physical dependence and non-sedative properties as distinguishing features relative to other anxiety drugs.³

The catch with buspirone is patience. Unlike benzodiazepines, which can calm anxiety within an hour, buspirone takes two to four weeks of daily use before it reaches full effectiveness. People who have previously taken fast-acting sedatives sometimes feel like buspirone “isn’t working” and give up too early. It also does not help with acute panic attacks because of that slow onset. But for steady, background anxiety that grinds on day after day, buspirone offers genuine relief without the fog that sedating medications produce. Its most common side effects are mild and tend to include dizziness, headache, and nausea rather than sleepiness.

Beta-Blockers for Physical Symptoms

If your anxiety shows up mostly as a racing heart, shaky hands, a quavering voice, or sweating before a presentation, beta-blockers like propranolol address those physical symptoms directly. Propranolol blocks the effects of adrenaline on the heart and muscles, so the visible and felt manifestations of the fight-or-flight response get dialed down. It has been studied for performance anxiety, stage fright, and some aspects of post-traumatic stress.⁴

Beta-blockers do not act on the brain’s sedation pathways the way benzodiazepines or antihistamines do, so drowsiness is generally not a prominent side effect. Some people report feeling a bit tired or sluggish, especially at higher doses, because their heart rate and blood pressure drop. But that is a different sensation from the cognitive fog and heavy eyelids caused by sedating drugs. Worth noting: beta-blockers do not treat the psychological component of anxiety (the ruminating thoughts, the dread, the worry). They quiet the body, not the mind. For that reason, they work best as a targeted tool for specific situations rather than as a daily anxiety treatment.

Medications That Do Cause Drowsiness

Understanding which medications are non-sedating is easier when you know what sits on the other end of the spectrum. The biggest culprits for drowsiness in anxiety treatment are benzodiazepines (such as alprazolam, lorazepam, and diazepam), sedating antihistamines (like hydroxyzine), and gabapentinoids (gabapentin and pregabalin). Each of these works through pathways in the brain that, by their very nature, tend to slow things down.

Benzodiazepines enhance the effect of GABA, the brain’s main inhibitory chemical, across the board. That means they reduce anxiety quickly but also reduce alertness, coordination, and reaction speed. Hydroxyzine blocks histamine receptors, the same receptors targeted by over-the-counter sleep aids like diphenhydramine. Research has confirmed that hydroxyzine enhances the sedating effects of anesthetics, underscoring just how strongly it suppresses wakefulness.⁵

Gabapentinoids are sometimes prescribed off-label for anxiety, and pregabalin is approved for generalized anxiety disorder in some countries outside the United States. A meta-analysis in Molecular Psychiatry found that gabapentinoids commonly cause side effects tied to central nervous system depression, including drowsiness and dizziness, and these effects may raise the risk of falls and traffic accidents.⁶ A separate review noted that while dizziness and somnolence are the most frequently reported side effects of pregabalin, tolerance to these effects tends to develop within a few weeks.⁷ So even within the “sedating” category, the picture is not static: some people find the drowsiness fades with time.

Driving, Reaction Time, and Real-World Function

Even when a medication is classified as “non-sedating,” you should pay attention to how it actually affects your daily performance. Drowsiness is the most obvious concern, but subtler cognitive impairments, like slower reaction times or reduced alertness, can matter just as much if you are behind the wheel or operating equipment. A review published in Heliyon found that anxiolytics in general can affect cognitive and behavioral components involved in driving, including increased weaving within a lane and changes in reaction time.⁸

The practical takeaway is that starting any new anxiety medication warrants a period of self-monitoring. Even SSRIs, which rarely cause drowsiness, can produce dizziness or lightheadedness in the first week or two. Most prescribers will recommend that you avoid driving or high-stakes tasks until you know how a new medication affects you personally. This adjustment period is usually brief, but skipping it can have real consequences.

Older Adults Face a Narrower Menu

Age changes the risk-benefit calculation for almost every anxiety medication. Older adults metabolize drugs more slowly, are more sensitive to sedation, and face higher stakes from side effects like dizziness and impaired coordination because falls can be devastating. A review in Current Treatment Options in Psychiatry concluded that both benzodiazepines and beta-blockers should generally be avoided when treating anxiety in the elderly.⁹ Beta-blockers make the list not because of sedation per se, but because lowering heart rate and blood pressure in an older person increases the risk of falls from dizziness.

That leaves SSRIs and buspirone as the safest pharmacological options for older adults who need anxiety treatment without drowsiness. SSRIs still require careful dosing in this population since drug clearance is slower, and starting doses are typically lower than in younger adults. Buspirone’s lack of sedation and absence of dependence risk make it especially appealing for elderly patients, though the delayed onset of action can be frustrating when someone is in acute distress.

Newer Antidepressants and Cognitive Effects

A newer generation of antidepressants has been designed with more precise receptor targeting, which can translate into cleaner side-effect profiles. Vortioxetine is one example: it acts on multiple serotonin receptor subtypes simultaneously, and unlike older drugs, it appears to improve cognitive functioning rather than impair it. A study in patients with major depressive episodes found that vortioxetine significantly improved both physical and cognitive symptoms over the course of treatment.¹⁰ Separate research has confirmed that vortioxetine may improve cognitive functioning in depression broadly and is effective for relapse prevention.¹¹

While vortioxetine is primarily approved for depression rather than anxiety as a standalone indication, anxiety and depression overlap so heavily that many people being treated for one condition benefit from treatment of the other. For someone whose anxiety comes packaged with brain fog or difficulty concentrating, a medication that addresses both without causing sedation can be more useful than one that treats anxiety alone. Nausea is its most common side effect, especially at higher doses, which tends to diminish after the first couple of weeks.

Supplements and Over-the-Counter Options

People who want to avoid prescription medications altogether sometimes turn to herbal supplements for anxiety. The most studied of these is kava, a plant native to the South Pacific. A systematic review in Nutrition Journal noted that the appeal of kava is specifically that it reduces anxiety without causing sedation or mental impairment, side effects that are typical of benzodiazepines.¹² The proposed mechanism involves effects on GABA receptors, sodium and calcium channels, and monoamine systems, which gives it a pharmacological profile quite different from a simple sedative herb.

However, kava comes with its own concerns. Reports of liver toxicity led several countries to restrict or ban kava products in the early 2000s, and while some of those bans have been relaxed, the safety picture remains complicated. Quality control in the supplement industry is inconsistent, so what you actually get in a capsule can vary widely between brands. If you are considering kava or any other supplement, it is worth discussing with a prescriber, especially if you take other medications, because interactions are possible even with “natural” products.

When You Stop a Non-Sedating Medication

A question that often gets overlooked when choosing an anxiety medication is what happens when you stop taking it. Discontinuation effects are real, especially with SSRIs and SNRIs. A review in Deutsches Ärzteblatt International reported that withdrawal symptoms from antidepressants are usually mild and self-limiting, with the most common being dizziness, headache, sleep disturbances, and mood swings.¹³ Rebound anxiety, where symptoms temporarily flare up worse than before treatment, has not been well studied for most antidepressants, so the data on how often that actually happens is thin.

Tapering slowly rather than stopping abruptly makes a significant difference. SSRIs with shorter half-lives, like paroxetine, tend to cause more noticeable withdrawal effects than those with longer half-lives, like fluoxetine. This is worth considering when choosing a medication upfront: if you think you might want to stop treatment eventually, a drug that is easier to taper off of has practical advantages beyond its side-effect profile during active use.

Combining Medication with Therapy

Many people assume that taking a non-sedating medication alongside cognitive behavioral therapy (CBT) will give them the best of both worlds. The intuition makes sense, but the research is surprisingly mixed. A review in Clinical Psychology: Science and Practice found that combining medication with CBT for anxiety disorders in adults has not consistently produced substantially better outcomes than either treatment alone.¹⁴ One hypothesis for why is that some medications may blunt the emotional engagement needed for therapy to work, essentially making it harder for the brain to fully process and reconsolidate fear-related memories during exposure exercises.

This does not mean you should avoid combining the two. For many individuals, the combination works well in practice even if the aggregate research shows modest additive benefit. The point is that medication and therapy are not simply additive in a straightforward way, and your prescriber and therapist may want to coordinate the timing and type of each intervention. A non-sedating medication has an advantage here too, since being alert and cognitively sharp during therapy sessions likely matters for getting the most out of them.

What Researchers Are Working On

The reason benzodiazepines cause so much sedation is that they activate GABA receptors indiscriminately. Your brain has several subtypes of these receptors, and only some of them are involved in anxiety. Others control sedation, muscle relaxation, and memory. For decades, researchers have been trying to build drugs that activate only the anxiety-related subtypes while leaving the sedation-related subtypes alone. An experimental compound called TPA023 demonstrated this concept in preclinical and early human testing: it acted as a partial agonist at the GABA receptor subtypes linked to anxiety (alpha-2 and alpha-3) while largely sparing those linked to sedation. In rats and primates, TPA023 functioned as a non-sedating anxiolytic. In human volunteers, it did not impair postural stability or cognition the way lorazepam did.¹⁵

TPA023 itself did not make it to market, partly due to preclinical toxicity findings in long-term animal studies, but the principle it demonstrated has kept the field alive. Several pharmaceutical companies continue to develop subtype-selective GABA modulators. If one of these eventually reaches approval, it would represent the first truly new class of non-sedating anxiolytic since buspirone arrived in the 1980s. For now, though, the existing toolkit of SSRIs, SNRIs, and buspirone remains the backbone of non-sedating anxiety treatment, and for most people, those options work well enough that the wait for something better is manageable.